Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Unlike earlier single or dual incretin-based therapies, Retatrutide is known as a triple hormone receptor agonist, acting simultaneously on GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors
Serious Risks & Warnings Not FDA-approved: Melanotan II is not an approved medication
This means it aids in weight loss by: Regulating blood sugar levels Reducing appetite Slowing digestion Importantly, Tirzepatide does not increase energy or alertness , so most users do not experience sleep disruptions associated with stimulant-based medications
Ramachandran A, Lebofsky M, Weinman SA, Jaeschke H
Andersen JV (2025) The glutamate/GABAglutamine cycle: insights, updates, and advances
J Biol Chem 287:98629872 Tourrel C, Bailbe D, Meile MJ, Kergoat M, Portha B (2001) Glucagon-like peptide-1 and exendin-4 stimulate -cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age
US$ 27.57
US$ 29.09
US$ 22.93
US$ 20.65
US$ 23.53
US$ 26.44
